CLINICAL_TRIALS
trial_result
· 2014-04-01
Clinical Trial Update: PS-341 Followed by Removal of Prostate for Those With Prostate Cancer [Phase 2]
Summary
A Phase 2 trial of PS-341 (bortezomib) followed by prostate removal in prostate cancer patients has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Prostate Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2014-04-01